An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that ...

Despite a trend toward more patient-centered research, quality-of-life end points remain substantially underreported in phase ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

Systematic review shows GLP 1 receptor agonists trials rarely assess dietary intake, highlighting a major evidence gap in nutrition outcomes.

Remote clinical pharmacist impact on reducing total cost of care in Enhancing Oncology Model–enrolled oncology practices. Electronic patient-reported outcome-based weight management versus usual care ...

Study of 850 participants believed to be the largest randomized, placebo-controlled trial ever conducted on a single food ingredient, brain health, and immunity. BAINBRIDGE ISLAND, WA / ACCESS ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.

Study of 850 participants believed to be the largest randomized, placebo-controlled trial ever conducted on a single food ingredient, brain health, and immunity. BAINBRIDGE ISLAND, WA / ACCESS Newswir ...